drugset
drugset / Trial / NCT03141658

Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects

NCT03141658 ↗

Phase 1 Completed 63 enrolled Taisho Pharmaceutical R&D Inc.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate the effects of TS-134 on ketamine-induced BOLD signals in ROIs in resting fMRI in healthy adult subjects.

Timeline

Start
2017-06-28
Primary completion
2018-04-04
Completion
2018-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-134 Unknown 20 mg —
Subject TS-134 Unknown 60 mg —

Indications

No indication recorded.